Your browser doesn't support javascript.
loading
Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis.
Yu, Jeong Il; Kang, Wonseok; Yoo, Gyu Sang; Goh, Myung Ji; Sinn, Dong Hyun; Gwak, Geum-Youn; Paik, Yong-Han; Choi, Moon Seok; Lee, Joon Hyeok; Koh, Kwang Cheol; Paik, Seung Woon; Hong, Jung Yong; Lim, Ho Yeong; Park, Boram; Park, Hee Chul.
Afiliação
  • Yu JI; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Kang W; Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea.
  • Yoo GS; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, South Korea.
  • Goh MJ; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Sinn DH; Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea.
  • Gwak GY; Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea.
  • Paik YH; Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea.
  • Choi MS; Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea.
  • Lee JH; Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea.
  • Koh KC; Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea.
  • Paik SW; Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea.
  • Hong JY; Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea.
  • Lim HY; Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea.
  • Park B; Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea.
  • Park HC; Biomedical Statistics Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, South Korea.
Front Oncol ; 12: 888755, 2022.
Article em En | MEDLINE | ID: mdl-35646674

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul País de publicação: Suíça